Profile of Resistance of Human Immunodeficiency Virus to Mannose-Specific Plant Lectins

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Virology

• Publication date

  2004-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.78.19.10617-10627.2004PMID 15367629PMCID PMC516383
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mannose-Specific Plant Lectins from the Amaryllidaceae Family Qualify as Efficient Microbicides for Prevention of Human Immunodeficiency Virus Infection

  2004cited by this paper
• Cyanovirin-N Gel as a Topical Microbicide Prevents Rectal Transmission of SHIV89.6P in Macaques

  2003cited by this paper
• Inhibition of DC‐SIGN‐mediated trans infection of T cells by mannose‐binding lectin

  2003cited by this paper
• Antibody neutralization and escape by HIV-1

  2003influential reference
• Biochemical and Biological Characterization of a Dodecameric CD4-Ig Fusion Protein

  2002cited by this paper
• The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of α1→2 Mannose Residues on the Outer Face of gp120

  2002cited by this paper
• High Mannose Glycans and Sialic Acid on gp120 Regulate Binding of Mannose-Binding Lectin (MBL) to HIV Type 1

  2002cited by this paper
• N-Linked Glycosylation of the HIV Type-1 gp120 Envelope Glycoprotein as a Major Determinant of CCR5 and CXCR4 Coreceptor Utilization*

  2001cited by this paper
• SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo

  2001cited by this paper
• Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner.

  2001cited by this paper
• Protection of Neutralization Epitopes in the V3 Loop of Oligomeric Human Immunodeficiency Virus Type 1 Glycoprotein 120 by N-Linked Oligosaccharides in the V1 Region

  2001cited by this paper
• A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure

  2000cited by this paper
• O-Linked Glycosylation in Focus

  2000cited by this paper
• Analysis of the interaction between the HIV-inactivating protein cyanovirin-N and soluble forms of the envelope glycoproteins gp120 and gp41.

  2000cited by this paper
• Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters.

  2000cited by this paper
• A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity.

  1999influential reference
• The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine.

  1999cited by this paper
• Host cell glycosylation of viral glycoproteins--a battlefield for host defence and viral resistance.

  1998cited by this paper
• The antigenic structure of the HIV gp120 envelope glycoprotein

  1998cited by this paper
• Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

  1998influential reference
• A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding.

  1998cited by this paper
• Handbook of plant lectins : properties and biomedical applications

  1998cited by this paper
• Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

  1998cited by this paper
• Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4

  1997influential reference
• Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development

  1997cited by this paper
• Development of resistance of human immunodeficiency virus type 1 to dextran sulfate associated with the emergence of specific mutations in the envelope gp120 glycoprotein.

  1997cited by this paper
• Marked inhibitory activity of non-nucleoside reverse transcriptase inhibitors against human immunodeficiency virus type 1 when combined with (-)2',3'-dideoxy-3'-thiacytidine.

  1996cited by this paper
• The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication

  1996cited by this paper
• Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

  1996cited by this paper
• The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

  1996cited by this paper
• The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

  1996cited by this paper
• HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

  1996cited by this paper
• The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

  1996cited by this paper
• Rapid selection for an N-linked oligosaccharide by monoclonal antibodies directed against the V3 loop of human immunodeficiency virus type 1.

  1996cited by this paper
• A General Model for the Surface Glycoproteins of HIV and Other Retroviruses

  1995cited by this paper
• Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells

  1995cited by this paper
• Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells.

  1995cited by this paper
• Knocking-out concentrations of HIV-1-specific inhibitors completely suppress HIV-1 infection and prevent the emergence of drug-resistant virus.

  1993cited by this paper
• Neutralizing antibody response during human immunodeficiency virus type 1 infection: type and group specificity and viral escape.

  1993influential reference
• Carbohydrates of human immunodeficiency virus.

  1992cited by this paper
• The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro.

  1992cited by this paper
• Alpha-(1-3)- and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro

  1991cited by this paper
• Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.

  1990cited by this paper
• Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1.

  1990cited by this paper
• Correlation between carbohydrate structures on the envelope glycoprotein gp120 of HIV-1 and HIV-2 and syncytium inhibition with lectins.

  1989cited by this paper
• Related mannose‐specific lectins from different species of the family Amaryllidaceae

  1988cited by this paper
• Carbohydrate structures of the human-immunodeficiency-virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese-hamster ovary cells.

  1988cited by this paper
• Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120.

  1988cited by this paper
• Structural characterization by chromatographic profiling of the oligosaccharides of human immunodeficiency virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese hamster ovary cells.

  1987cited by this paper
• Isolation and characterization of a lectin with exclusive specificity towards mannose from snowdrop (Galanthus nivalis) bulbs

  1987cited by this paper

• In Silico and in vitro evaluation of Cucurbitaceae seed lectins as promising prophylactic and therapeutic agents against SARS-CoV-2

  2025cites this paper
• Antiviral Lectins of the Plant Family Amaryllidaceae

  2023influential citation
• Legume Lectins with Different Specificities as Potential Glycan Probes for Pathogenic Enveloped Viruses

  2022cites this paper
• 35 years in plant lectin research: a journey from basic science to applications in agriculture and medicine

  2021cites this paper
• Lectins Are the Sparkle of Hope for Combating Coronaviruses and the Global COVID-19

  2021cites this paper
• Emerging and state of the art hemagglutinin-targeted influenza virus inhibitors.

  2020cites this paper
• Development of a lectin-Fc fusion protein with antiviral and anti-cancer activity.

  2019cites this paper
• Overview of the Structure–Function Relationships of Mannose-Specific Lectins from Plants, Algae and Fungi

  2019cites this paper
• Human Cervical Epithelial Cells Release Antiviral Factors and Inhibit HIV Replication in Macrophages

  2018cites this paper
• Protein regulation and Apoptotic induction in human breast carcinoma cells (MCF-7) through lectin from G. beauts.

  2017cites this paper
• Antiviral lectins: Selective inhibitors of viral entry

  2017cites this paper
• Bioactive compounds in a Manayi traditional medicinal product from East London

  2016influential citation
• Vesicular stomatitis virus (VSV) as a paradigm for predicting antiviral activity against Ebola virus (EBOV)

  2015cites this paper
• Genus: Calanthe to Cyrtosia

  2015cites this paper
• NICTABA and UDA, two GlcNAc-binding lectins with unique antiviral activity profiles

  2015cites this paper
• Targeting N-Glycan Cryptic Sugar Moieties for Broad-Spectrum Virus Neutralization: Progress in Identifying Conserved Molecular Targets in Viruses of Distinct Phylogenetic Origins

  2015cites this paper
• Antiviral Activity of Synthetic Aminopyrrolic Carbohydrate Binding Agents: Targeting the Glycans of Viral gp120 to Inhibit HIV Entry.

  2015cites this paper
• Evaluation of selected Namibian ethno-medicinal plants for anti-HIV properties

  2015cites this paper
• HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth

  2015cites this paper
• The evolution of HIV-1 interactions with coreceptors and mannose C-type lectin receptors.

  2015cites this paper
• Evaluation of the safety and pharmacokinetic profile of the broad spectrum antiviral lectin Griffithsin.

  2014cites this paper
• Bitter-sweet symphony: glycan–lectin interactions in virus biology

  2014cites this paper
• Phytoconstituents as potential anti-HIV agents: A Systematic review

  2014cites this paper
• Exposure of HIV-1 to a combination of two carbohydrate-binding agents markedly delays drug resistance development and selects for virus strains with compromised fitness.

  2014cites this paper
• Ebola virus (EBOV) infection: Therapeutic strategies

  2014influential citation
• The role of N-glycans of HIV-1 gp41 in virus infectivity and susceptibility to the suppressive effects of carbohydrate-binding agents

  2014cites this paper
• [A new mannose-specific lectin from daylily (Hemerocallis fulva L.) rhizome: purification and properties].

  2013cites this paper
• Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVN.

  2013cites this paper
• Inhibition of hepatitis C virus by the cyanobacterial protein Microcystis viridis lectin: mechanistic differences between the high-mannose specific lectins MVL, CV-N, and GNA.

  2013cites this paper
• Entry inhibitors directed towards glycoprotein gp120: an overview on a promising target for HIV-1 therapy.

  2013cites this paper
• Inhibition of infection and transmission of HIV-1 and lack of significant impact on the vaginal commensal lactobacilli by carbohydrate-binding agents.

  2013cites this paper
• Virus Glycoproteins Tagged with the Human Fc Domain as Second Generation Vaccine Candidates

  2012cites this paper
• Purification and characterization of a novel plant lectin from Pinellia ternata with antineoplastic activity

  2012cites this paper
• Molecular architecture and therapeutic potential of lectin mimics

  2012cites this paper
• Activity and safety of synthetic lectins based on benzoboroxole-functionalized polymers for inhibition of HIV entry.

  2011cites this paper
• Carbohydrate Binding Agents: Potential Therapeutics with Multiple Inhibitory Actions against Enveloped Viruses

  2011cites this paper
• The Hepatitis C Virus Glycan Shield and Evasion of the Humoral Immune Response

  2011cites this paper
• Differences in the mannose oligomer specificities of the closely related lectins from Galanthus nivalis and Zea mays strongly determine their eventual anti-HIV activity

  2011cites this paper
• Synergistic in vitro anti-HIV type 1 activity of tenofovir with carbohydrate-binding agents (CBAs).

  2011cites this paper
• Targeting HIV entry through interaction with envelope glycoprotein 120 (gp120): synthesis and antiviral evaluation of 1,3,5-triazines with aromatic amino acids.

  2011cites this paper
• Profile of systemic treatment with the antiviral lectin Griffithsin in guinea pigs.

  2011cites this paper
• The Highly Conserved Glycan at Asparagine 260 of HIV-1 gp120 Is Indispensable for Viral Entry*

  2011cites this paper
• Pradimicin S, a Highly Soluble Nonpeptidic Small-Size Carbohydrate-Binding Antibiotic, Is an Anti-HIV Drug Lead for both Microbicidal and Systemic Use

  2010cites this paper
• Pradimicin S, a highly-soluble non-peptidic small-size carbohydrate-binding antibiotic,

  2010cites this paper
• A new chitin-binding lectin from rhizome of Setcreasea purpurea with antifungal, antiviral and apoptosis-inducing activities

  2010cites this paper
• Ethnomedicinal plants and other natural products with anti-HIV active compounds and their putative modes of action

  2010influential citation
• Actinohivin, a Broadly Neutralizing Prokaryotic Lectin, Inhibits HIV-1 Infection by Specifically Targeting High-Mannose-Type Glycans on the gp120 Envelope

  2010cites this paper
• Slow binding-tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation.

  2010cites this paper
• Fundamental Difference in the Content of High-Mannose Carbohydrate in the HIV-1 and HIV-2 Lineages

  2010cites this paper
• Anionic Polysaccharides From Phototrophic Microorganisms Exhibit Antiviral Activities to Vaccinia Virus

  2010cites this paper
• A Derivate of the Antibiotic Doxorubicin Is a Selective Inhibitor of Dengue and Yellow Fever Virus Replication In Vitro

  2010cites this paper
• Potential of carbohydrate‐binding agents as therapeutics against enveloped viruses

  2010cites this paper
• New classes of anti-HIV-1 compounds active at different stages of infection

  2009cites this paper
• Long-Lasting Enfuvirtide Carrier Pentasaccharide Conjugates with Potent Anti-Human Immunodeficiency Virus Type 1 Activity

  2009cites this paper
• Targeting cells for drug and gene delivery: Emerging applications of mannans and mannan binding lectins

  2009cites this paper
• Clematis montana lectin, a novel mannose-binding lectin from traditional Chinese medicine with antiviral and apoptosis-inducing activities

  2009cites this paper
• Human Immunodeficiency Virus Type 1 Escape from Cyclotriazadisulfonamide-Induced CD4-Targeted Entry Inhibition Is Associated with Increased Neutralizing Antibody Susceptibility

  2009cites this paper
• The Phthalocyanine Prototype Derivative Alcian Blue Is the First Synthetic Agent with Selective Anti-Human Immunodeficiency Virus Activity Due to Its gp120 Glycan-Binding Potential

  2009cites this paper
• Lectinomics I. Relevance of exogenous plant lectins in biomedical diagnostics

  2009cites this paper
• Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection.

  2009influential citation
• Characterisation of the lectin microvirin from Microcystis aeruginosa PCC 7806 and new insights into the role of microcystin

  2009cites this paper
• Nebrodeolysin, a novel hemolytic protein from mushroom Pleurotus nebrodensis with apoptosis-inducing and anti-HIV-1 effects.

  2009cites this paper
• Safety concerns for the potential use of cyanovirin-N as a microbicidal anti-HIV agent.

  2008cites this paper
• PEGylation of cyanovirin-N, an entry inhibitor of HIV.

  2008cites this paper
• Glycan deletions in the HIV-1 gp120 V1/V2 domain compromise viral infectivity, sensitize the mutant virus strains to carbohydrate-binding agents and represent a specific target for therapeutic intervention.

  2008cites this paper
• Plant-Derived Leading Compounds for Chemotherapy of Human Immunodefiency Virus (HIV) Infection – An Update (1998 – 2007)

  2008cites this paper
• Hemaglutinina de folhas de mandioca (Manihot esculenta Crantz): purificação parcial e toxicidade

  2008cites this paper
• Carbohydrates on HIV: mediators of immune evasion and targets for antiviral intervention

  2008cites this paper
• Simian Immunodeficiency Virus Is Susceptible to Inhibition by Carbohydrate-Binding Agents in a Manner Similar to That of HIV: Implications for Further Preclinical Drug Development

  2008cites this paper
• Antiviral activity of carbohydrate-binding agents against Nidovirales in cell culture

  2007cites this paper
• Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions.

  2007cites this paper
• Viruses and Viral Diseases

  2007cites this paper
• Carbohydrate-Binding Agents: A Potential Future Cornerstone for the Chemotherapy of Enveloped Viruses?

  2007cites this paper
• Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy

  2007cites this paper
• Defining carbohydrate antigens as HIV vaccine candidates.

  2007cites this paper
• Evaluation of antivirals against corona- and lentiviruses in cell cultures

  2007cites this paper
• The carbohydrate-binding plant lectins and the non-peptidic antibiotic pradimicin A target the glycans of the coronavirus envelope glycoproteins

  2007cites this paper
• Design and Synthesis of Novel Sultams: A Family of Non-nucleoside Reverse Transcriptase Inhibitors and Modeling Studies of a Rhodium Catalyst

  2007cites this paper
• Immunogenicity of the outer domain of a HIV-1 clade C gp120

  2007cites this paper
• Strict specificity for high-mannose type N-glycans and primary structure of a red alga Eucheuma serra lectin.

  2007cites this paper
• Status Presens of Antiviral Drugs And Strategies: Part I: DNA Viruses and Retroviruses

  2007cites this paper
• Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12.

  2007cites this paper
• Sialic Acid on Herpes Simplex Virus Type 1 Envelope Glycoproteins Is Required for Efficient Infection of Cells

  2007cites this paper
• The α(1,2)‐mannosidase I inhibitor 1‐deoxymannojirimycin potentiates the antiviral activity of carbohydrate‐binding agents against wild‐type and mutant HIV‐1 strains containing glycan deletions in gp120

  2007cites this paper
• Glycosylation of HIV-1 gp120 V3 loop: towards the rational design of a synthetic carbohydrate vaccine.

  2007cites this paper
• Primary Structure and Carbohydrate Binding Specificity of a Potent Anti-HIV Lectin Isolated from the Filamentous Cyanobacterium Oscillatoria agardhii*

  2007cites this paper
• Pradimicin A, a Carbohydrate-Binding Nonpeptidic Lead Compound for Treatment of Infections with Viruses with Highly Glycosylated Envelopes, Such as Human Immunodeficiency Virus

  2006influential citation
• A guided tour through the antiviral drug field

  2006cites this paper
• Evaluation of current strategies to inhibit HIV entry, integration and maturation

  2006influential citation
• Anti-HIV I/II activity and molecular cloning of a novel mannose/sialic acid-binding lectin from rhizome of Polygonatum cyrtonema Hua.

  2006cites this paper
• Inhibition of HIV entry by carbohydrate-binding proteins.

  2006cites this paper
• Glycosylation of beet western yellows virus proteins is implicated in the aphid transmission of the virus

  2006cites this paper
• Inhibitors of HIV infection via the cellular CD4 receptor.

  2006cites this paper
• Dendritic cell-mediated HIV-1 transmission

  2006cites this paper
• Relevance of plant lectins in human cell biology and immunology.

  2006cites this paper
• Large-molecular-weight carbohydrate-binding agents as HIV entry inhibitors targeting glycoprotein gp120

  2006cites this paper
• Mutational Pathways, Resistance Profile, and Side Effects of Cyanovirin Relative to Human Immunodeficiency Virus Type 1 Strains with N-Glycan Deletions in Their gp120 Envelopes

  2006cites this paper
• Sugar-Binding Proteins Potently Inhibit Dendritic Cell Human Immunodeficiency Virus Type 1 (HIV-1) Infection and Dendritic-Cell-Directed HIV-1 Transfer

  2005cites this paper
• Carbohydrate-binding Agents Cause Deletions of Highly Conserved Glycosylation Sites in HIV GP120

  2005cites this paper
• Resistance of Human Immunodeficiency Virus Type 1 to the High-Mannose Binding Agents Cyanovirin N and Concanavalin A

  2005cites this paper